No evidence for association between polymorphism in GRM3 and schizophrenia

Nadine Norton, Hywel J. Williams, Sarah Dwyer, Dobril Ivanov, Anna C. Preece, Amy Gerrish, Nigel M. Williams, Pamela Yerassimou, Stanley Zammit, Michael C. O'Donovan, Michael J. Owen

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Background: Three studies have previously reported data that were interpreted by the authors as supportive of association between schizophrenia and polymorphisms in the gene encoding the metabotropic glutamate receptor GRM3. Methods: In a bid to examine this hypothesis, we examined seven SNPs spanning GRM3 in a UK case-control sample (schizophrenic cases n = 674, controls n = 716). These included all SNPs previously reported to be associated, alone or in haplotypes, with schizophrenia in European or European American samples. Results: Our data showed no evidence for association with single markers, or 2, 3, 4 and 5 marker haplotypes, nor did any specific haplotypes show evidence for association according to previously observed patterns. Conclusion: Examination of our own data and those of other groups leads us to conclude that at present, GRM3 should not be viewed as a gene for which there is replicated evidence for association with schizophrenia.

Original languageEnglish (US)
Article number23
JournalBMC Psychiatry
StatePublished - May 13 2005

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'No evidence for association between polymorphism in GRM3 and schizophrenia'. Together they form a unique fingerprint.

Cite this